By Samuel Howard ( April 26, 2010, 12:57 PM EDT) -- Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over the generic-drug maker's attempt to market its own version of blockbuster drug Ritalin, a treatment for attention deficit hyperactivity disorder....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.